|

An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer Survivors

RECRUITINGN/ASponsored by University of Michigan Rogel Cancer Center
Actively Recruiting
PhaseN/A
SponsorUniversity of Michigan Rogel Cancer Center
Started2026-09-15
Est. completion2028-09
Eligibility
Age18 Years – 39 Years
Healthy vol.Accepted
Locations1 site

Summary

This clinical trial studies whether an artificial intelligence (AI)-powered supportive care chatbot is helpful for addressing the supportive care needs of young adult cancer survivors. Young adult cancer survivors often experience ongoing and distressing symptoms following treatment, including extreme tiredness and lack of energy, anxiety, and difficulty sleeping. Young adult cancer survivors report a variety of strategies to self-manage these symptoms; however, there remains a gap in targeted interventions focused on the needs in young adult survivors. The AI-powered supportive care chatbot is designed to provide evidence-based information on supportive care for young adult cancer survivors. Users interact with the chatbot by entering free-text questions or selecting from predefined topics to receive tailored educational responses related to supportive care across the cancer continuum, including treatment effects, symptom management, care transitions, and life after cancer. The AI-powered supportive care chatbot may be an effective way to help address the supportive care needs of young adult cancer survivors.

Eligibility

Age: 18 Years – 39 YearsHealthy volunteers accepted
Inclusion Criteria:

* 18 - 39 years old
* Able to speak/read English
* Completed primary cancer treatment (e.g., surgery, radiation, chemotherapy, immunotherapy) at least one month prior to the time of consent. Although, participants will be eligible if they are receiving maintenance treatments
* Report at least one moderate to severe symptom, side effect, or supportive care concern from cancer or its treatment
* Able to access Wi-Fi/internet
* Willing to complete surveys electronically

Exclusion Criteria:

* Completed cancer treatment more than three years ago

Conditions3

CancerHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Locations1 site

University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109
Robert Knoerl734-764-8617rjknoerl@med.umich.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.